KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Cost of Revenue (2016 - 2025)

Bausch Health Companies' Cost of Revenue history spans 17 years, with the latest figure at -$144.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 56.89% year-over-year to -$144.0 million; the TTM value through Dec 2025 reached $5.0 million, down 98.56%, while the annual FY2025 figure was $5.0 million, 25.0% up from the prior year.
  • Cost of Revenue for Q4 2025 was -$144.0 million at Bausch Health Companies, down from $14.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $2.3 billion in Q4 2021 and bottomed at -$1.8 billion in Q4 2023.
  • The 5-year median for Cost of Revenue is $12.5 million (2022), against an average of $152.4 million.
  • The largest YoY upside for Cost of Revenue was 7011.11% in 2023 against a maximum downside of 36580.0% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $2.3 billion in 2021, then crashed by 99.78% to $5.0 million in 2022, then crashed by 36580.0% to -$1.8 billion in 2023, then skyrocketed by 81.69% to -$334.0 million in 2024, then surged by 56.89% to -$144.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Cost of Revenue are -$144.0 million (Q4 2025), $14.0 million (Q3 2025), and $33.0 million (Q2 2025).